TAKEDA UK LIMITED

Active United Kingdom

Wholesale of pharmaceutical goods

278 employees website.com
Wholesale of pharmaceutical goods
T

TAKEDA UK LIMITED

Wholesale of pharmaceutical goods

Founded 25 Apr 1997 Active United Kingdom 278 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 4 Jan 2026 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 29 Apr 2026 Next due 9 May 2027 11 months remaining
Net assets £182M £17M 2024 year on year
Total assets £318M £9M 2024 year on year
Total Liabilities £136M £26M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Website

www.example.com

Full company profile for TAKEDA UK LIMITED (03362860), an active company based in United Kingdom. Incorporated 25 Apr 1997. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Net Assets

£182.20M

Increased by £17.27M (+10%)

Total Liabilities

£136.08M

Decreased by £25.98M (-16%)

Turnover

£584.99M

Increased by £68.98M (+13%)

Employees

278

Decreased by 13 (-4%)

Debt Ratio

43%

Decreased by 7 (-14%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Roffe, Emma Jane, DrDirectorBritishUnited Kingdom5412 Dec 2022Active

Shareholders

Shareholders (1)

Takeda Pharmaceuticals International Ag
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Takeda Pharmaceutical Company Limited

Japan

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Takeda Pharmaceuticals International Ag

Ceased 6 Apr 2016

Ceased

Group Structure

Group Structure

TAKEDA UK LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
Level 9, 1 Kingdom Street, London (W2 6BD) CITY OF WESTMINSTER
Leasehold-26 Oct 2021
Unit 3, Globeside Business Park, Fieldhouse Lane, Marlow (SL7 1HZ) BUCKINGHAMSHIRE
Leasehold-8 Oct 2012
Level 9, 1 Kingdom Street, London (W2 6BD)
Leasehold
Added 26 Oct 2021
District CITY OF WESTMINSTER
Unit 3, Globeside Business Park, Fieldhouse Lane, Marlow (SL7 1HZ)
Leasehold
Added 8 Oct 2012
District BUCKINGHAMSHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026Confirmation StatementConfirmation statement made on 25 Apr 2026 with no updates
4 Jan 2026AccountsAnnual accounts made up to 31 Mar 2025
11 Nov 2025OfficersAppointment of Mr Itaru Miura as director on 4 Nov 2025
10 Sept 2025OfficersTermination of Peter Michael Grubin as director on 2 Sept 2025
10 Jul 2025OfficersChange to director Mr Peter Michael Grubin on 29 May 2025
29 Apr 2026 Confirmation Statement

Confirmation statement made on 25 Apr 2026 with no updates

4 Jan 2026 Accounts

Annual accounts made up to 31 Mar 2025

11 Nov 2025 Officers

Appointment of Mr Itaru Miura as director on 4 Nov 2025

10 Sept 2025 Officers

Termination of Peter Michael Grubin as director on 2 Sept 2025

10 Jul 2025 Officers

Change to director Mr Peter Michael Grubin on 29 May 2025

Recent Activity

Latest Activity

Confirmation statement made on 25 Apr 2026 with no updates

3 weeks ago on 29 Apr 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 4 Jan 2026

Appointment of Mr Itaru Miura as director on 4 Nov 2025

6 months ago on 11 Nov 2025

Termination of Peter Michael Grubin as director on 2 Sept 2025

8 months ago on 10 Sept 2025

Change to director Mr Peter Michael Grubin on 29 May 2025

10 months ago on 10 Jul 2025